Kezar Life Sciences, Inc. (KZR)
Largest Insider Buys in Sector
KZR Stock Price History Chart
KZR Stock Performance
About Kezar Life Sciences, Inc.
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products …
Insider Activity of Kezar Life Sciences, Inc.
Over the last 12 months, insiders at Kezar Life Sciences, Inc. have bought $0 and sold $3,879 worth of Kezar Life Sciences, Inc. stock.
On average, over the past 5 years, insiders at Kezar Life Sciences, Inc. have bought $9.65M and sold $1.31M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 20,000 shares for transaction amount of $295,400 was made by BERGER FRANKLIN M () on 2022‑03‑18.
List of Insider Buy and Sell Transactions, Kezar Life Sciences, Inc.
| 2024-07-02 | Sale | Chief Legal Officer | 6,688 0.0084% | $0.58 | $3,879 | +10.53% | ||
| 2023-02-06 | Sale | 10 percent owner | 40,000 0.0558% | $6.88 | $275,320 | -69.99% | ||
| 2023-02-03 | Sale | 10 percent owner | 25,000 0.0348% | $7.15 | $178,650 | -70.14% | ||
| 2023-02-02 | Sale | 10 percent owner | 50,000 0.0681% | $7.19 | $359,500 | -70.86% | ||
| 2023-02-01 | Sale | 10 percent owner | 40,000 0.0558% | $6.95 | $278,000 | -68.99% | ||
| 2023-01-31 | Sale | 10 percent owner | 30,000 0.041% | $7.08 | $212,400 | -70.01% | ||
| 2023-01-30 | Sale | 10 percent owner | 30,000 0.041% | $6.91 | $207,300 | -68.71% | ||
| 2023-01-25 | Sale | director | 50,000 0.0697% | $6.85 | $342,500 | -67.35% | ||
| 2023-01-24 | Sale | director | 80,000 0.1103% | $6.98 | $558,400 | -68.05% | ||
| 2023-01-23 | Sale | director | 80,000 0.1109% | $6.81 | $544,800 | -66.76% | ||
| 2023-01-17 | Sale | director | 6,114 0.0088% | $6.79 | $41,514 | -64.18% | ||
| 2023-01-13 | Sale | director | 1,971 0.0029% | $7.15 | $14,093 | -65.50% | ||
| 2023-01-12 | Sale | director | 5,000 0.0068% | $6.77 | $33,850 | -65.80% | ||
| 2023-01-06 | Sale | director | 3,000 0.0042% | $6.89 | $20,670 | -65.20% | ||
| 2023-01-05 | Sale | director | 12,162 0.017% | $6.97 | $84,769 | -65.51% | ||
| 2023-01-04 | Sale | director | 30,000 0.0414% | $7.17 | $215,100 | -66.90% | ||
| 2023-01-03 | Sale | director | 500 0.0007% | $7.10 | $3,550 | -65.66% | ||
| 2022-12-29 | Sale | director | 25,000 0.0375% | $7.10 | $177,500 | -66.15% | ||
| 2022-10-04 | Sale | director | 3,612 0.0056% | $8.82 | $31,857 | -64.16% | ||
| 2022-10-03 | Sale | director | 28,700 0.0425% | $8.78 | $251,957 | -65.34% |
Insider Historical Profitability
| Equal Talent Investments Ltd | 10 percent owner | 6254545 85.7231% | $7.45 | 1 | 0 | +13.64% |
| Morningside Venture Investments Ltd | 10 percent owner | 5447993 74.6687% | $7.45 | 2 | 19 | +42.12% |
| Cormorant Asset Management, LP | 10 percent owner | 1572909 21.5579% | $7.45 | 1 | 0 | +15.16% |
| BERGER FRANKLIN M | 890691 12.2076% | $7.45 | 4 | 0 | +11.46% | |
| BAY CITY CAPITAL LLC | 10 percent owner | 622229 8.5281% | $7.45 | 1 | 0 | +15.16% |
Institutional Investor Ownership
| Suvretta Capital Management, LLC | $6.46M | 9.85 | 7.17M | 0% | +$0 | 0.27 | |
| Avidity Partners Management Lp | $4.53M | 6.9 | 5.03M | +0.01% | +$492.27 | 0.17 | |
| BlackRock | $4.16M | 6.34 | 4.62M | -4.16% | -$180,570.67 | <0.0001 | |
| The Vanguard Group | $2.79M | 4.25 | 3.09M | +1% | +$27,715.19 | <0.0001 | |
| Sphera Fund | $1.85M | 2.82 | 2.05M | 0% | +$0 | 0.01 |